Designed for residual solvent analysis of pharmaceutical compounds per US Pharmacopeia Method <467>.

• Engineered to optimize pharmaceutical residual solvents analysis per USP Method <467>
• Ultra inertness and low bleed
• Resolution of USP regulated critical pairs, also separates benzene and 1,2-dichloroethane
• Identical selectivity to the popular VF-624 ms – upgrade with no changes in method
• UI testing ensures premium performance column to column
• Tested against the strictest industry QC specifications for column bleed, sensitivity and efficiency
• Performance Summary shipped with each column

Agilent J&W DB-Select 624 UI <467> is designed specifically for United States Pharmacopoeia Method <467>. Equivalent to USP phase G43, this stationary phase is engineered for the best sensitivity and resolution of the critical pairs specified in <467> for the analysis of residual solvents in active pharmaceutical ingredients.